The regulation of cancer and aging by methionine
蛋氨酸对癌症和衰老的调节
基本信息
- 批准号:10750559
- 负责人:
- 金额:$ 61.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-03-31
- 项目状态:未结题
- 来源:
- 关键词:4T1AddressAdultAffectAgeAgingAmino AcidsAnabolismAnimal Cancer ModelAnimalsBiologicalBreast Cancer CellBreast Cancer ModelBreast CarcinomaCell Culture TechniquesCell modelCellsDNA MethylationDNA Modification MethylasesDNA Modification ProcessDependenceDevelopmentDietDietary ComponentDietary InterventionDietary ProteinsDiseaseEnsureEpigenetic ProcessFrequenciesGene Expression ProfilingGenetic TranscriptionHealthHealth BenefitHigh PrevalenceHumanImmunodeficient MouseInbred StrainInbreedingIndividualIntegration Host FactorsInterventionKnowledgeLinkLongevityMaintenanceMalignant NeoplasmsMammary NeoplasmsMapsMediatingMediatorMetabolicMetabolismMethionineMethionine Metabolism PathwayModelingMolecularMorbidity - disease rateMouse StrainsMusNeoplasm MetastasisNormal tissue morphologyPathologyPathway interactionsPersonsPhenotypePlantsPlayPopulationPreventionProcessPropertyProtein KinaseRattusRegulationResearchResistanceRodentRoleS-AdenosylhomocysteineS-AdenosylmethionineSocietiesTechniquesTestingTumor PromotionTumor TissueVegan DietWorkXenograft procedureage effectage relatedagedanti-canceranticancer researchantitumor effectcancer initiationcancer therapydietarydietary restrictionepigenetic profilingepigenomeexperimental studygenetic approachhealthspanhealthy aginghistone methylationhistone methyltransferasehistone modificationimprovedin vivoinsightinterestjuvenile animalmalignant breast neoplasmmetabolic phenotypemodel organismmortalitymouse modelmultidisciplinarymutantnovelolder womenpatient derived xenograft modelpharmacologicpreventresponseself-renewalsensorstemtumortumor growthtumor initiationtumor progressiontumorigenesis
项目摘要
Project Summary
Age-related diseases, including cancer, are the major causes of morbidity and mortality in Western
society. While cancer in the genetically heterogeneous human population primarily occurs in the aged, cancer
research to-date has primarily utilized young, inbred animals. As the effect of aging and host factors on cancer
development and progression has grown increasingly evident, the limitations of this approach have become
clear. Understanding how aging impacts cancer development, progression, and the response to interventions
will provide mechanistic insights into the prevention and treatment of cancer as individuals grow older, and
eventually will permit the development of new pharmacological approaches to this age-associated disease that
will enable healthy aging.
Here, we build on recent work by our team and others demonstrating that restricting dietary protein, or
restriction of specific dietary amino acids, can extend the lifespan and healthspan of mice. We will utilize
methionine restriction (MR), a dietary intervention that extends longevity and improves metabolic health in mice,
and which in mouse xenograft studies has been shown to slow the progression of certain cancers, including
breast cancer, the most common cancer in older women. Limitations of MR research to date include the fact that
the effect of MR on healthspan is limited in scope, that the effects of MR have been studied only in a few young
mouse strains, and that the cancer studies done to-date have exclusively relied on young hosts.
Understanding how MR affects the healthspan, longevity, and natural development of breast cancer
during the aging of genetically heterogeneous mice will provide valuable new insights into the potential
application of MR-based interventions for the health, longevity and treatment of cancer in the genetically
heterogeneous human population. We will use cutting edge techniques to isolate and characterize cancer
initiating cells (CICs), examine how changes in levels of methionine and its metabolites affect the epigenome.
We will use two breast tumor models to examine how host age impacts CICs, tumor growth and/or metastasis
and the response to MR. Finally, we will determine the role of specific molecular sensors of methionine
metabolites in the epigenetic and anti-cancer effects of MR during aging. The proposed work will address long-
standing questions regarding the molecular mechanisms by which dietary components regulate healthy aging
and cancer.
项目摘要
与年龄有关的疾病,包括癌症,是西方发病率和死亡率的主要原因
社会。尽管遗传异质人口中的癌症主要发生在老年人中,但癌症
待日期的研究主要利用了年轻的近交动物。作为衰老和宿主因素对癌症的影响
发展和发展越来越明显,这种方法的局限性已成为
清除。了解衰老如何影响癌症的发展,进展和对干预措施的反应
随着个体的年龄增长,将提供有关癌症预防和治疗的机械见解,并且
最终将允许开发与这种年龄相关疾病的新药理方法
将使健康的衰老。
在这里,我们以团队和其他人的最新工作为基础,证明了限制饮食蛋白的限制或
限制特定的饮食氨基酸可以延长小鼠的寿命和健康状态。我们将利用
蛋氨酸限制(MR),一种饮食干预措施,可延长寿命并改善小鼠的代谢健康,
并且在小鼠异种移植研究中的研究已证明会减慢某些癌症的进展,包括
乳腺癌是老年女性最常见的癌症。迄今为止先生研究的局限性包括以下事实
MR对HealthSpan的影响的范围有限,仅在少数年轻人中研究了MR的效果
小鼠菌株,并且迄今为止所做的癌症研究仅依赖于年轻宿主。
了解MR如何影响乳腺癌的健康状况,寿命和自然发展
在遗传性异构小鼠衰老期间,将为潜力提供宝贵的新见解
基于MR的干预措施在遗传上的健康,寿命和治疗癌症的健康,寿命和治疗
异构人口。我们将使用尖端技术来隔离和表征癌症
引发细胞(CICS),检查蛋氨酸及其代谢物水平的变化如何影响表观基因组。
我们将使用两种乳腺肿瘤模型来检查宿主年龄如何影响CIC,肿瘤生长和/或转移
以及对先生的反应。最后,我们将确定蛋氨酸特定分子传感器的作用
MR在衰老过程中的表观遗传和抗癌作用中的代谢产物。拟议的工作将长期解决
关于饮食成分调节健康衰老的分子机制的常规问题
和癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VINCENT L. CRYNS其他文献
VINCENT L. CRYNS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VINCENT L. CRYNS', 18)}}的其他基金
alphaBeta-crystallin: A Novel Biomarker in Breast Cancer
αβ-晶状体蛋白:乳腺癌的新型生物标志物
- 批准号:
7187693 - 财政年份:2007
- 资助金额:
$ 61.97万 - 项目类别:
alphaBeta-crystallin: A Novel Biomarker in Breast Cancer
αβ-晶状体蛋白:乳腺癌的新型生物标志物
- 批准号:
7340131 - 财政年份:2007
- 资助金额:
$ 61.97万 - 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
- 批准号:
6711150 - 财政年份:2003
- 资助金额:
$ 61.97万 - 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
- 批准号:
6856542 - 财政年份:2003
- 资助金额:
$ 61.97万 - 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
- 批准号:
6615904 - 财政年份:2003
- 资助金额:
$ 61.97万 - 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
- 批准号:
7032982 - 财政年份:2003
- 资助金额:
$ 61.97万 - 项目类别:
Role of alphaB-Crystallin in Cancer Cell Death
αB-晶状体蛋白在癌细胞死亡中的作用
- 批准号:
7188600 - 财政年份:2003
- 资助金额:
$ 61.97万 - 项目类别:
MOLECULAR PATHOGENESIS OF PARATHYROID NEOPLASIA
甲状旁腺肿瘤的分子发病机制
- 批准号:
2084410 - 财政年份:1993
- 资助金额:
$ 61.97万 - 项目类别:
MOLECULAR PATHOGENESIS OF HUMAN PARATHYROID ADENOMAS
人甲状旁腺腺瘤的分子发病机制
- 批准号:
3034824 - 财政年份:1993
- 资助金额:
$ 61.97万 - 项目类别:
MOLECULAR PATHOGENESIS OF PARATHYROID NEOPLASIA
甲状旁腺肿瘤的分子发病机制
- 批准号:
2084408 - 财政年份:1993
- 资助金额:
$ 61.97万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Mechanisms underlying the protective effect of exercise and weight maintenance on metastatic progression in breast cancer
运动和体重维持对乳腺癌转移进展的保护作用的机制
- 批准号:
9321998 - 财政年份:2016
- 资助金额:
$ 61.97万 - 项目类别:
Immunotherapy to Mitigate the Negative Effects of Alcohol on Cancer Progression
减轻酒精对癌症进展的负面影响的免疫疗法
- 批准号:
8795141 - 财政年份:2014
- 资助金额:
$ 61.97万 - 项目类别:
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
(PQA2) 哺乳动物再生、高脂肪饮食和乳腺癌:共同的联系?
- 批准号:
9086307 - 财政年份:2013
- 资助金额:
$ 61.97万 - 项目类别:
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
(PQA2) 哺乳动物再生、高脂肪饮食和乳腺癌:共同的联系?
- 批准号:
8899472 - 财政年份:2013
- 资助金额:
$ 61.97万 - 项目类别:
Development of TGF-beta antagonists for cancer therapy
开发用于癌症治疗的 TGF-β 拮抗剂
- 批准号:
9153704 - 财政年份:
- 资助金额:
$ 61.97万 - 项目类别: